Isoliquiritigenin inhibits virus replication and virus-mediated inflammation via NRF2 signalingArticle Published on 2023-06-012023-06-24 Journal: Phytomedicine : international journal of phytother [Category] 신종인플루엔자, [키워드] antiviral activity Inflammation Isoliquiritigenin Nrf2. [DOI] 10.1016/j.phymed.2023.154786 PMC 바로가기
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitorsArticle Published on 2023-02-052023-07-11 Journal: European journal of medicinal chemistry [Category] COVID19(2023년), [키워드] antiviral activity COVID-19 Michael acceptors Peptide-based inhibitors SARS-CoV-2 M(pro) inhibition. [DOI] 10.1016/j.ejmech.2022.115021 PMC 바로가기
Green Synthesized Zinc Oxide Nanoparticles Based on Cestrum diurnum L. of Potential Antiviral Activity against Human Corona 229-E VirusArticle Published on 2022-12-282023-07-11 Journal: Molecules [Category] COVID19(2023년), [키워드] antiviral activity Cestrum diurnum L. Coronaviruses HPLC quantification human corona 229E Zinc oxide nanoparticles. [DOI] 10.3390/molecules28010266 PMC 바로가기
Sulfonamides with Heterocyclic Periphery as Antiviral AgentsReview Published on 2022-12-212023-07-11 Journal: Molecules [Category] COVID19(2023년), [키워드] antiviral activity azines azoles morpholine multi-step syntheses N-heterocycles piperidine sulfonamide. [DOI] 10.3390/molecules28010051 PMC 바로가기 [Article Type] Review
Synthesis, Anti-Influenza H1N1 and Anti-Dengue Activity of A-Ring Modified Oleanonic Acid Polyamine DerivativesArticle Published on 2022-12-022023-06-23 Journal: Molecules [Category] 신종인플루엔자, [키워드] antiviral activity benzylidene dengue virus indole influenza A (H1N1) oleanolic acid polyamine triterpenoids. Ugi derivatives [DOI] 10.3390/molecules27238499 PMC 바로가기
Identification and characterization of the anti-SARS-CoV-2 activity of cationic amphiphilic steroidal compounds양이온성 양친매성 스테로이드 화합물의 항 SARS-CoV-2 활성의 확인 및 특성화Article Published on 2022-12-012022-09-11 Journal: Virulence [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 치료제, [키워드] aggravation ameliorated anti-SARS-CoV-2 activities Anti-SARS-CoV-2 Activity Antiviral antiviral activity cationic caused cell lines characterization cholesterol complex Compound compounds COVID-19 pandemic COVID-19 patient cytopathic Cytopathic effect Drug discovery effective envelope envelope proteins epiandrosterone followed by hACE2 HEK293 host cell host cells identification in vitro in vivo indicated inhibited initial involved life Lipid mechanism membrane modulate modulation Mortality Pathogenesis progeny protective effect Protective effects Proteins Quality of life reduce reduce COVID-19 aggravation SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 replication selected Selection single mutation single mutations specific treatment spike steroidal compounds. subversion Transgenic mouse translate transmembrane Treatment treatment of COVID-19 patients Vero Vero CCL81 cell Vero CCL81 cells viral replication Viral RNA viral variant Viral variants [DOI] 10.1080/21505594.2022.2085793 PMC 바로가기 [Article Type] Article
Pulmonary delivery of favipiravir inhalation solution for COVID-19 treatment: in vitro characterization, stability, in vitro cytotoxicity, and antiviral activity using real time cell analysisArticle Published on 2022-12-012022-11-15 Journal: Drug Delivery [Category] COVID19(2023년), SARS, 치료제, [키워드] addition administration Analysis Antiviral antiviral activity Calu-3 Cell characterized Concentration COVID-19 cytotoxicity Favipiravir in vitro indicated Influenza virus Inhaled inhaled formulation inhibitor investigated lung lung epithelial cell lung tissue Lungs media Patient patients with COVID-19 PBS phosphate buffer profile pulmonary RdRP real time required respiratory. RNA-dependent RNA polymerase SARS-CoV-2 stability target Toxicity treat Treatment VERO-E6 viability were infected [DOI] 10.1080/10717544.2022.2118398 PMC 바로가기
Natural products from medicinal plants in Asia and the Pacific for RNA viruses: Hercules’ fifth labourArticle Published on 2022-12-012022-11-15 Journal: Pharmaceutical Biology [Category] 치료제, [키워드] active against analysis antiviral activity antiviral drug antiviral drugs Asia Asian ChemSpider Direct distribution Google Scholar Hercule hydroxytyrosol identify in vivo material molecular natural plant PubChem RNA RNA virus RNA virus Science Treatment viral genome replication viral infections virus virus Web of Science with COVID-19 zoonotic [DOI] 10.1080/13880209.2022.2130944 PMC 바로가기
SARS-CoV-2 fusion-inhibitory lipopeptides maintain high potency against divergent variants of concern including OmicronSARS-CoV-2 융합 억제 리포펩티드는 오미크론을 포함한 다양한 관심 변종에 대해 높은 효능을 유지합니다Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 치료제, [키워드] activity Alpha antiviral activity Beta broad-spectrum antiviral broad-spectrum antivirals Cell Cell fusion cell-cell fusion combating COVID-19 pandemic D614G Delta drugs effective vaccine Effective vaccines exhibited FIVE fusion inhibitor Gamma Impact Infection inhibiting inhibitor inhibitors Lambda lipopeptide maintain mutant omicron Omicron variant other variant other variants outbreak pseudovirus pseudovirus pseudovirus infection pseudoviruses reduced S protein S proteins SARS-CoV-2 significantly the S protein therapeutic variant variants variants of concern variants of concern. VoC VOCs wild-type WT virus [DOI] 10.1080/22221751.2022.2098060 PMC 바로가기 [Article Type] Article
Zinc pyrithione is a potent inhibitor of PL Pro and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication아연 피리티온은 SARS-CoV-2 진입 및 복제를 생체 외에서 억제하는 PL Pro 및 카텝신 L 효소의 강력한 억제제입니다.Article Published on 2022-12-012022-09-11 Journal: Journal of Enzyme Inhibition and Medicinal Chemist [Category] COVID19(2023년), SARS, 치료제, [키워드] analogue Anti-SARS-CoV-2 Activity Antiviral antiviral activity Antiviral agents assays cathepsin L comparable complex complexes contrary COVID-19 effective enzyme Enzymes evaluated Ex vivo expressed human lung tissue in vitro inhibition inhibitor involved Ligand media Pro pyrithione Replication ruthenium SARS-CoV-2 SARS-CoV-2 entry stability synthesised therapeutic therapeutic agent Zinc Zinc complexes Zinc pyrithione zinc. [DOI] 10.1080/14756366.2022.2108417 PMC 바로가기 [Article Type] Article